Moreover, enhanced tumor growth through upregulation of the epidermal growth factor receptor (EGFR) and cancer cell survival through interaction with phosphatidylinositol 3-kinase/(PI3K)/AKT [9,10] also trigger tumor progression. This evidence concerns the gene EGFR and neoplasm.